FDA says Glaxo drug may be linked to birth defect
Fri, 29 Sep 2006 04:06 PM EST
... WASHINGTON (Reuters) - Taking GlaxoSmithKline Plc's Lamictal epilepsy drug during the first three months of pregnancy may increase the chances of having a baby with a cleft lip or palate, U.S. regulators warned on Friday. ...
Related Topics
- Birth Defects
- Heart Defects
- Birth Centers
- Drug Safety
- Thalidomide
- Birth Control
- Births, Deaths & Marriages
- Neural Tube Defects
- Ondansetron
- Cesarean Birth
- Birth Control Side Effects
- Prescription Drugs
- Lesch-Nyhan Syndrome
- Emergency Contraception
- Drug Side Effects
- Colestipol
- Drug Abuse
- Drug Information
- Prescription Drug Abuse
- Prescription Drugs Abuse

Not Signed In -


